在Sjögren病的临床试验和新疗法
Vishal Patel1, Antonio Salas1, Thomas Grader-Beck1
1Johns Hopkins School of Medicine, Baltimore, MD 21224, USA.
Current opinion in immunology
|March 4, 2026
概括
尽管在Sjögren的进步.
科学领域:
- 风湿病学和免疫学
- 自免疫性疾病 自免疫性疾病
- 临床治疗学 临床治疗学
背景情况:
- 斯约格伦病 (SjD) 缺乏经批准的疾病修饰疗法,需要症状管理.
- 目前的治疗方法往往涉及非标签免疫调节剂,这突出了针对性SjD治疗的重大未满足需求.
- 治疗SjD的治疗场景正在发展,有前途的临床试验结果.
研究的目的:
- 审查目前Sjögren病治疗开发的现状.
- 突出SjD临床试验的最新进展,包括2期和3期研究.
- 讨论改进的试验设计对评估新型SjD治疗方法的影响.
主要方法:
- 对Sjögren病治疗的最近第二期和第三期临床试验数据的审查.
- 从研究ianalumab和telitacicept的试验中分析疗效信号.
- 检查SjD研究中不断发展的临床试验设计原则.
主要成果:
- 第二阶段试验表明,新型SjD治疗的有效性信号具有意义.
- 对ianalumab和telitacicept的第三阶段试验显示出积极的结果,特别是在减少系统性疾病活性方面 (EULAR Sjögren综合征疾病活动指数).
- 精细的试验设计,包括患者选择和终点开发,对于成功至关重要.
结论:
- 斯乔格伦病可能正在进入有效的疾病修饰疗法的时代.
- 最近的临床试验成功表明,SjD的治疗管道正在成熟.
- 优化试验方法对于准确评估SjD治疗疗效至关重要.
更多相关视频
相关概念视频
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
616
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
616
Myasthenia Gravis: Overview and Treatment
3.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Nephrotic Syndrome II : Assessment and Medical Management
285
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
285


